BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/17/2023 6:20:53 AM | Browse: 156 | Download: 496
Publication Name World Journal of Gastroenterology
Manuscript ID 80054
Country/Territory United Arab Emirates
Received
2022-09-15 10:13
Peer-Review Started
2022-09-15 10:16
To Make the First Decision
Return for Revision
2022-11-15 08:02
Revised
2023-01-06 15:29
Second Decision
2023-03-03 03:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-03-07 18:47
Articles in Press
2023-03-07 18:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
2023-03-13 00:56
Typeset the Manuscript
2023-03-14 01:39
Publish the Manuscript Online
2023-03-17 06:20
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
Manuscript Source Invited Manuscript
All Author List Khansa Ahsan, Munir Ahmad Anwar and Nayla Munawar
ORCID
Author(s) ORCID Number
Nayla Munawar http://orcid.org/0000-0001-9448-2845
Funding Agency and Grant Number
Corresponding Author Nayla Munawar, PhD, Assistant Professor, Chemistry, United Arab Emirates University, College of Science, United Arab Emirates University, Al Ain 15551, United Arab Emirates. nmunawar@uaeu.ac.ae
Key Words COVID-19; Gut-liver axis; Probiotics; Prebiotics; Cytokines; Gut microbiome
Core Tip There are several reviews in the literature contributed to the pathophysiology of liver damage during severe acute respiratory syndrome coronavirus 2 infection. However, we highlight the potential role of gut microbiota in managing drug-induced liver damage during and after coronavirus disease 2019 (COVID-19) infection. We shed light on various metabolites produced by gut microorganisms that have a significant role in reducing liver damage in COVID-19 infection with the use of different probiotics and prebiotics.
Publish Date 2023-03-17 06:20
Citation Ahsan K, Anwar MA, Munawar N. Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients. World J Gastroenterol 2023; 29(11): 1708-1720
URL https://www.wjgnet.com/1007-9327/full/v29/i11/1708.htm
DOI https://dx.doi.org/10.3748/wjg.v29.i11.1708
Full Article (PDF) WJG-29-1708.pdf
Full Article (Word) WJG-29-1708.docx
Manuscript File 80054-Review-FilipodiaCL.docx
Answering Reviewers 80054-Answering reviewers.pdf
Audio Core Tip 80054-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 80054-Conflict-of-interest statement.pdf
Copyright License Agreement 80054-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 80054-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 80054-Language certificate.pdf
Peer-review Report 80054-Peer-review(s).pdf
Scientific Misconduct Check 80054-Bing-Liu GL-2.png
Scientific Editor Work List 80054-Scientific editor work list.pdf